Glycosylation regulates NK cell-mediated effector function through PI3K pathway

International Immunology

Volumn 22, Issue 3, 2010, Pages 167-177

  Benson, Veronika ^a   Grobarova, Valika ^a   Richter, Jan ^a   Fiserova, Anna ^a  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Cytotoxic activity; Gene regulation; Glycoconjugate; Glycosyltransferases; NK cells; NK 92; NKG2D

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; GLUCOSYLTRANSFERASE; GLUCOSYLTRANSFERASE MGAT3; GLUCOSYLTRANSFERASE MGAT5; INTERLEUKIN 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINE CALIX[4]ARENE; NATURAL KILLER CELL RECEPTOR NKG2D; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOWN REGULATION; DRUG SENSITIVITY; ENZYME ACTIVITY; GENE EXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACYLTRANSFERASES; CELL LINE; CELL PROLIFERATION; CELL SEPARATION; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOCONJUGATES; GLYCOSYLATION; HT29 CELLS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASMS; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 77949876533     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp123     Document Type: Article

References (29)

1. Apweiler, R., Hermjakob, H. and Sharon, N. 1999. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1473:4.
2. Yoshimura, M., Nishikawa, A., Ihara, Y. et al. 1995. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc. Natl Acad. Sci. USA 92:8754.
3. Fernandes, B., Sagman, U., Auger, M. et al. 1991. Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res. 51:718.
4. Yoshimura, M., Nishikawa, A., Ihara, Y. et al. 1995. High expression of UDP-N-acetylglucosamine: beta-D mannoside beta-1,4-N-acetylglucosaminyltransferase III (GnT-III) in chronic myelogenous leukemia in blast crisis. Int. J. Cancer 60:443.
5. Ohyama, C., Kanto, S., Kato, K. et al. 2002. Natural killer cells attack tumor cells expressing high levels of sialyl Lewis x oligosaccharides. Proc. Natl Acad. Sci. USA 99:13789.
6. Raulet, D. H. 2004. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat. Immunol. 5:996.
7. Li, C., Ge, B., Nicotra, M. et al. 2008. JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity. Proc. Natl Acad. Sci. USA 105:3017.
8. Poggi, A. and Zocchi, M. R. 2006. Antigen presenting cells and stromal cells trigger human natural killer lymphocytes to auto-reactivity: evidence for the involvement of natural cytotoxicity receptors (NCR) and NKG2D. Clin. Dev. Immunol. 13:325.
9. Chen, X., Trivedi, P. P., Ge, B. et al. 2007. Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity. Proc. Natl Acad. Sci. USA 104:6329.
10. Bezouska, K., Yuen, C. T., O'Brien, J. et al. 1994. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 372:150.
11. Krenek, K., Kuldova, M., Hulikova, K. et al. 2007. N-acetyl-D-glucosamine substituted calix[4]arenes as stimulators of NK cell-mediated antitumor immune response. Carbohydr. Res. 342:1781.
12. Yao, A. Y., Tang, H. Y., Wang, Y. et al. 2004. Inhibition of the activating signals in NK92 cells by recombinant GST-sHLA-G1a chain. Cell Res. 14:155.
13. Weihua, Z., Tsan, R., Huang, W. C. et al. 2008. Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell 13:385.
14. Ullmannova, V., Stockbauer, P., Hradcova, M. et al. 2003. Relationship between cyclin D1 and p21(Waf1/Cip1) during differentiation of human myeloid leukemia cell lines. Leuk. Res. 27:1115.
15. Han, Y., San-Marina, S., Yang, L. et al. 2007. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells. Breast Cancer Res. 9:R43.
16. Hemdan, N. Y., Lehmann, I., Wichmann, G. et al. 2007. Immunomodulation by mercuric chloride in vitro: application of different cell activation pathways. Clin. Exp. Immunol. 148:325.
17. Hasan, N., Yusuf, N., Toossi, Z. and Islam, N. 2006. Suppression of Mycobacterium tuberculosis induced reactive oxygen species Modulation of NK cells by GC 177 (ROS) and TNF-alpha mRNA expression in human monocytes by allicin. FEBS Lett. 580:2517.
18. Fiserova, A., Starec, M., Kuldova, M. et al. 2002. Effects of D2-dopamine and alpha-adrenoceptor antagonists in stress induced changes on immune responsiveness of mice. J. Neuroimmunol. 130:55.
19. Ullmannova, V. and Popescu, N. C. 2007. Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines. Cancer Detect. Prev. 31:110.
20. Bezouska, K. 2002. Design, functional evaluation and biomedical applications of carbohydrate dendrimers (glycodendrimers). J. Biotechnol. 90:269.
21. Vannucci, L., Fiserova, A., Sadalapure, K. et al. 2003. Effects of N-acetyl-glucosamine-coated glycodendrimers as biological modulators in the B16F10 melanoma model in vivo. Int. J. Oncol. 23:285.
22. Rademacher, T. W., Parekh, R. B. and Dwek, R. A. 1988. Glycobiology. Annu. Rev. Biochem. 57:785.
23. Tam, Y. K., Martinson, J. A., Doligosa, K. and Klingemann, H. G. 2003. Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy. Cytotherapy 5:259.
24. Yoon, S. R., Chung, J. W. and Choi, I. 2007. Development of natural killer cells from hematopoietic stem cells. Mol. Cells 24:1.
25. Saito, S., Nishikawa, K., Morii, T. et al. 1993. Cytokine production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. Int. Immunol. 5:559.
26. Storkus, W. J. and Dawson, J. R. 1991. Target structures involved in natural killing (NK): characteristics, distribution, and candidate molecules. Crit. Rev. Immunol. 10:393.
27. Pertovaara, L., Kaipainen, A., Mustonen, T. et al. 1994. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J. Biol. Chem. 269:6271.
28. Roberts, A. B., Sporn, M. B., Assoian, R. K. et al. 1986. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl Acad. Sci. USA 83:4167.
29. Dings, R. P., Chen, X., Hellebrekers, D. M. et al. 2006. Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities. J. Natl Cancer Inst. 98:932.